Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
Two data points from Table 1. (continued) were published in error. The corrected data in Table 1. (continued) are shown, in italic, below.